News Industry News New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation February 25, 2020
News Industry News Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation July 01, 2019
News Industry News Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies October 08, 2015